Normal hepatic glucose production in the absence of GLUT2 reveals an alternative pathway for glucose release from hepatocytes.

Glucose production by liver is a major physiological function, which is required to prevent development of hypoglycemia in the postprandial and fasted states. The mechanism of glucose release from hepatocytes has not been studied in detail but was assumed instead to depend on facilitated diffusion through the glucose transporter GLUT2. Here, we demonstrate that in the absence of GLUT2 no other transporter isoforms were overexpressed in liver and only marginally significant facilitated diffusion across the hepatocyte plasma membrane was detectable. However, the rate of hepatic glucose output was normal. This was evidenced by (i) the hyperglycemic response to i.p. glucagon injection; (ii) the in vivo measurement of glucose turnover rate; and (iii) the rate of release of neosynthesized glucose from isolated hepatocytes. These observations therefore indicated the existence of an alternative pathway for hepatic glucose output. Using a [14C]-pyruvate pulse-labeling protocol to quantitate neosynthesis and release of [14C]glucose, we demonstrated that this pathway was sensitive to low temperature (12 degreesC). It was not inhibited by cytochalasin B nor by the intracellular traffic inhibitors brefeldin A and monensin but was blocked by progesterone, an inhibitor of cholesterol and caveolae traffic from the endoplasmic reticulum to the plasma membrane. Our observations thus demonstrate that hepatic glucose release does not require the presence of GLUT2 nor of any plasma membrane glucose facilitative diffusion mechanism. This implies the existence of an as yet unsuspected pathway for glucose release that may be based on a membrane traffic mechanism.

Selective absence of CD8+ TCRalpha beta+ intestinal epithelial cells in transgenic mice expressing beta2-microglobulin-associated ligands exclusively on thymic cortical epithelium.

Whereas interactions between the TCRalpha beta and self MHC:peptide complexes are clearly required for positive selection of mature CD4(+) and CD8(+) T cells during intrathymic development, the role of self or foreign ligands in maintaining the peripheral T cell repertoire is still controversial. In this report we have utilized keratin 14-beta2-microglobulin (K14-beta2m)-transgenic mice expressing beta2m-associated ligands exclusively on thymic cortical epithelial cells to address the possible influence of TCR:ligand interactions in peripheral CD8(+) T cell homeostasis. Our data indicate that CD8(+) T cells in peripheral lymphoid tissues are present in normal numbers in the absence of self MHC class I:peptide ligands. Surprisingly, however, steady state homeostasis of CD8(+) T cells in the intestinal epithelium is severely affected by the absence of beta2m-associated ligands. Indeed TCRalpha beta(+) IEL subsets expressing CD8alpha beta or CD8alpha alpha are both dramatically reduced in K14-beta2m mice, suggesting that the development, survival or expansion of CD8(+) IEL depends upon interaction of the TCR with MHC class I:peptide or other beta2m-associated ligands elsewhere than on thymic cortical epithelium. Collectively, our data reveal an unexpected difference in the regulation of CD8(+) T cell homeostasis by beta2m-associated ligands in the intestine as compared to peripheral lymphoid organs.

Fluorescence imaging reveals the nuclear behavior of peroxisome proliferator-activated receptor/retinoid X receptor heterodimers in the absence and presence of ligand.

In a global approach combining fluorescence recovery after photobleaching (FRAP), fluorescence correlation spectroscopy (FCS), and fluorescence resonance energy transfer (FRET), we address the behavior in living cells of the peroxisome proliferator-activated receptors (PPARs), a family of nuclear receptors involved in lipid and glucose metabolism, inflammation control, and wound healing. We first demonstrate that unlike several other nuclear receptors, PPARs do not form speckles upon ligand activation. The subnuclear structures that may be observed under some experimental conditions result from overexpression of the protein and our immunolabeling experiments suggest that these structures are subjected to degradation by the proteasome. Interestingly and in contrast to a general assumption, PPARs readily heterodimerize with retinoid X receptor (RXR) in the absence of ligand in living cells. PPAR diffusion coefficients indicate that all the receptors are engaged in complexes of very high molecular masses and/or interact with relatively immobile nuclear components. PPARs are not immobilized by ligand binding. However, they exhibit a ligand-induced reduction of mobility, probably due to enhanced interactions with cofactors and/or chromatin. Our study draws attention to the limitations and pitfalls of fluorescent chimera imaging and demonstrates the usefulness of the combination of FCS, FRAP, and FRET to assess the behavior of nuclear receptors and their mode of action in living cells.

Characterization of root apoplastic barriers in Arabidopsis thaliana

In vascular plants, the best-known feature of a differentiated endodermal cell is the "Casparian Strip" (CS). This structure refers to a highly localized cell wall impregnation in the transversal and anticlinal walls of the cell, which surrounds the cell like a belt/ring and is tightly coordinated with respect to neighboring cells. Analogous to tight junctions in animal epithelia, CS in plants act as a diffusion barrier that controls the movement of water and ions from soil into the stele. Since its first description by Robert Caspary in 1865 there have been many attempts to identify the chemical nature of the cell wall deposition in CS. Suberin, lignin, or both have been claimed to be the important components of CS in a series of different species. However, the exact chemical composition of CS has remained enigmatic. This controversy was due to the confusion and lack of knowledge regarding the precise measurement of three developmental stages of the endodermis. The CS represent only the primary stage of endodermal differentiation, which is followed by the deposition of suberin lamellae all around the cellular surface of endodermal cells (secondary developmental stage). Therefore, chemical analysis of whole roots, or even of isolated endodermal tissues, will always find both of the polymers present. It was crucial to clarify this point because this will guide our efforts to understand which cell wall biosynthetic component becomes localized in order to form the CS. The main aim of my work was to find out the major components of (early) CS, as well as their spatial and temporal development, physiological roles and relationship to barrier formation. Employing the knowledge and tools that have been accumulated over the last few years in the model plant Arabidopsis thaliana, various histological and chemical assays were used in this study. A particular feature of my work was to completely degrade, or inhibit formation of lignin and suberin biopolymers by biochemical, classical genetic and molecular approaches and to investigate its effect on CS formation and the establishment of a functional diffusion barrier. Strikingly, interference with monolignol biosynthesis abrogates CS formation and delays the formation of function diffusion barrier. In contrast, transgenic plants devoid of any detectable suberin still develop a functional CS. The combination of all these assays clearly demonstrates that the early CS polymer is made from monolignol (lignin monomers) and is composed of lignin. By contrast, suberin is formed much later as a secondary wall during development of endodermis. These early CS are functionally sufficient to block extracellular diffusion and suberin does not play important role in the establishment of early endodermal diffusion barrier. Moreover, suberin biosynthetic machinery is not present at the time of CS formation. Our study finally concludes the long-standing debate about the chemical nature of CS and opens the door to a new approach in lignin research, specifically for the identification of the components of the CS biosynthetic pathway that mediates the localized deposition of cell walls. I also made some efforts to understand the patterning and differentiation of endodermal passage cells in young roots. In the literature, passage cells are defined as a non- suberized xylem pole associated endodermal cells. Since these cells only contain the CS but not the suberin lamellae, it has been assumed that these cells may offer a continued low-resistance pathway for water and minerals into the stele. Thus far, no genes have been found to be expressed specifically in passage cells. In order to understand the patterning, differentiation, and physiological role of passage it would be crucial to identify some genes that are exclusively expressed in these cells. In order to identify such genes, I first generated fluorescent marker lines of stele-expressed transporters that have been reported to be expressed in the passage cells. My aim was to first highlight the passage cells in a non-specific way. In order to find passage cell specific genes I then adapted a two-component system based on previously published methods for gene expression profiling of individual cell types. This approach will allow us to target only the passage cells and then to study gene expression specifically in this cell type. Taken together, this preparatory work will provide an entry point to understand the formation and role of endodermal passage cells. - Chez les plantes vasculaires, la caractéristique la plus commune des cellules différentiées de l'endoderme est la présence de cadres de Caspary. Cette structure correspond à une imprégnation localisée des parties transversales et anticlinales de la paroi cellulaire. Cela donne naissance, autour de la cellule, à un anneau/cadre qui est coordonné par rapport aux cellules voisines. De manière analogue aux jonctions serrées des épithéliums chez les animaux, les cadres de Caspary agissent chez les plantes comme barrière de diffusion, contrôlant le mouvement de l'eau et des ions à travers la racine entre le sol et la stèle. Depuis leur première description par Robert Caspary en 1865, beaucoup de tentatives ont eu pour but de définir la nature chimique de ces cadres de Caspary. Après l'étude de différentes espèces végétales, à la fois la subérine, la lignine ou les deux ont été revendiquées comme étant des composants importants de ces cadres. Malgré tout, leur nature chimique exacte est restée longtemps énigmatique. Cette controverse provient de la confusion et du manque de connaissance concernant la détermination précise des trois stades de développement de l'endoderme. Les cadres de Caspary représentent uniquement le stade primaire de différentiation de l'endoderme. Celui-ci est suivi par le second stade de différentiation, la déposition de lamelles de subérine tout autour de la cellule endodermal. De ce fait, l'analyse chimique de racines entières ou de cellules d'endoderme isolées ne permet pas de séparer les stades de différentiation primaire et secondaire et aboutit donc à la présence des deux polymères. Il est également crucial de clarifier ce point dans le but de connaître quelle machinerie cellulaire localisée à la paroi cellulaire permet l'élaboration des cadres de Caspary. En utilisant les connaissances et les outils accumulés récemment grâce à la plante modèle Arabidopsis thaliana, divers techniques histologiques et chimiques ont été utilisées dans cette étude. Un point particulier de mon travail a été de dégrader ou d'inhiber complètement la formation de lignine ou de subérine en utilisant des approches de génétique classique ou moléculaire. Le but étant d'observer l'effet de l'absence d'un de ces deux polymères sur la formation des cadres de Caspary et l'établissement d'une barrière de diffusion fonctionnelle. De manière frappante, le fait d'interférer avec la voie de biosynthèse de monolignol (monomères de lignine) abolit la formation des cadres de Caspary et retarde l'élaboration d'une barrière de diffusion fonctionnelle. Par contre, des plantes transgéniques dépourvues d'une quantité détectable de subérine sont quant à elles toujours capables de développer des cadres de Caspary fonctionnels. Mises en commun, ces expériences démontrent que le polymère formant les cadres de Caspary dans la partie jeune de la racine est fait de monolignol, et que de ce fait il s'agit de lignine. La subérine, quant à elle, est formée bien plus tard durant le développement de l'endoderme, de plus il s'agit d'une modification de la paroi secondaire. Ces cadres de Caspary précoces faits de lignine suffisent donc à bloquer la diffusion extracellulaire, contrairement à la subérine. De plus, la machinerie de biosynthèse de la subérine n'est pas encore présente au moment de la formation des cadres de Caspary. Notre étude permet donc de mettre un terme au long débat concernant la nature chimique des cadres de Caspary. De plus, elle ouvre la porte à de nouvelles approches dans la recherche sur la lignine, plus particulièrement pour identifier des composants permettant la déposition localisée de ce polymère dans la paroi cellulaire. J'ai aussi fais des efforts pour mettre en évidence la formation ainsi que le rôle des cellules de passage dans les jeunes racines. Dans la littérature, les cellules de passage sont définies comme de la cellule endodermal faisant face aux pôles xylèmes et dont la paroi n'est pas subérisée. Du fait que ces cellules contiennent uniquement des cadres de Caspary et pas de lamelle de subérine, il a été supposé qu'elles ne devraient offrir que peu de résistance au passage de l'eau et des nutriments entre le sol et la stèle. Le rôle de ces cellules de passage est toujours loin d'être clair, de plus aucun gène s'exprimant spécifiquement dans ces cellules n'a été découvert à ce jour. De manière à identifier de tels gènes, j'ai tout d'abord généré des marqueurs fluorescents pour des transporteurs exprimés dans la stèle mais dont l'expression avait également été signalée dans l'endoderme, uniquement dans les cellules de passage. J'ai ensuite développé un système à deux composants basé sur des méthodes déjà publiées, visant principalement à étudier le profil d'expression génique dans un type cellulaire donné. En recoupant les gènes exprimés spécifiquement dans l'endoderme à ceux exprimés dans la stèle et les cellules de passage, il nous sera possible d'identifier le transriptome spécifique de ces cellules. Pris dans leur ensemble, ces résultats devraient donner un bon point d'entrée dans la définition et la compréhension des cellules de passage.

Absence of VLDL secretion does not affect alpha-tocopherol content in peripheral tissues

alpha-Tocopherol is a lipid-soluble antioxidant that helps to prevent oxidative damage to cellular lipids. alpha-Tocopherol is absorbed by the intestine and is taken up and retained by the liver; it is widely presumed that alpha-tocopherol is then delivered to peripheral tissues by the secretion of VLDL. To determine whether VLDL secretion is truly important for the delivery of alpha-tocopherol to peripheral tissues, we examined alpha-tocopherol metabolism in mice that lack microsomal triglyceride transfer protein (Mttp) expression in the liver and therefore cannot secrete VLDL (Mttp(Delta/Delta) mice). Mttp(Delta/Delta) mice have low plasma lipid levels and increased stores of lipids in the liver. Similarly, alpha-tocopherol levels in the plasma were lower in Mttp(Delta/Delta) mice than in controls, whereas hepatic alpha-tocopherol stores were higher. However, alpha-tocopherol levels in the peripheral tissues of Mttp(Delta/Delta) mice were nearly identical to those of control mice, suggesting that VLDL secretion is not critical for the delivery of alpha-tocopherol to peripheral tissues. When fed a diet containing deuterated alpha-tocopherol, Mttp(Delta/Delta) and control mice had similar incorporation of deuterated alpha-tocopherol into plasma and various peripheral tissues. We conclude that the absence of VLDL secretion has little effect on the stores of alpha-tocopherol in peripheral tissues, at least in the mouse.

PPAR beta a player in astrocyte metabolism and morphology

AbstractPPARP is a nuclear receptor responding in vivo to several free fatty acids, and implicated in cell metabolism, differentiation and survival. PPARp is ubiquitously expressed but shows high expression in the developing and adult brain. PPARp is expressed in different cell types such as neurons and astrocytes, where it might play a role in metabolism. To study this nuclear receptor the laboratory engineered a PPARP -/- mouse model. The aim of my PhD was to dissect the role of PPARP in astrocytes.Experiments in primary culture revealed that cortical astrocytes from PPARP -/- mouse have an impaired energetic metabolism. Unstimulated PPARP -/- astrocytes exhibit a 30% diminution in glucose uptake, correlating to a 30% decrease in lactate release and intracellular glucose. After acute stimulation by D- aspartate mimicking glutamate exposure, both WT and -/- astrocytes up-regulate their metabolism to respond to the increasing energy needed (ATP) for glutamate uptake. According to the Astrocyte Neuron Lactate Shuttle Hypothesis (ANLSH), the ratio between glucose uptake/ lactate release is 1. However, stimulated PPARp -/- astrocytes display a higher increase in lactate release than glucose uptake which remains lower than in WT. The extra glucose equivalents could come from the degradation of intra cellular glycogen stores, which indeed decrease in PPARP -/- cells upon stimulation. Lower glucose metabolism correlates with a decreased acute glutamate uptake in PPARP -/- astrocytes. Reciprocally, we also observed an increase of glutamate uptake and ATP production after treatment of WT astrocytes with a PPARp agonist. Glutamate transporter protein expression is not affected. However, their trafficking and localization might be altered as PPARp -/- astrocytes have higher cholesterol levels, which may also affect proper transporter structure in the membrane.Metabolism, transporter localization and cholesterol levels are respectively linked to cell mobility, cell cytoskeleton and cellular membrane composition. All three functions are important in astrocytes to in vivo acquire star shaped morphology, in a process known as stellation. PPARP -/- astrocytes showed an impaired acquired stellation in presence of neurons or chemical stimuli, as well as more actin stress fibers and cell adhesion structures. While non stellation of astrocytes is mainly an in vitro phenomenon, it reveals PPARp -/- primary astrocytes inability to respond to different exterior stimuli. These morphological phenotypes correlate with a slower migration in cell culture wound healing assays.This thesis work demonstrates that PPARp is implicated in cortical astrocyte glucose metabolism. PPARp absence leads to an unusual intracellular glycogen use. Added to the effect on acute glutamate uptake and astrocyte migration, PPARp could be an interesting target for neuroprotection therapies.RésuméPPARP est un récepteur nucléaire qui a pour ligands naturels certains acides gras libres. Il est impliqué dans le métabolisme, la différentiation et la survie des cellules. PPARP est ubiquitaire, et a une expression élevée dans le cerveau en développement ainsi qu'adulte. PPARp est exprimé dans différents types cellulaires tels que les neurones et les astrocytes, où il régule potentiellement leurs métabolismes. Pour étudier ce récepteur nucléaire, le laboratoire a créé un modèle de souris PPARp -/-. L'objectif de ma thèse est de comprendre le rôle de PPARp dans les astrocytes.Les expériences montrent un défaut du métabolisme énergétique dans les astrocytes corticaux primaires tirés de souris PPARp -/-. Sans stimulation, l'entrée du glucose dans les astrocytes PPARP -/- est diminuée de 30% ce qui correspond à une diminution de 30% du relargage du lactate. Après stimulation par du D-Aspartate qui mime une exposition au glutamate, les astrocytes WT et -/- augmentent leur métabolisme en réponse à la demande accrue en énergie (ATP) due à l'entrée du glutamate. D'après l'Astrocyte Neuron Lactate Shuttle Hypothesis (ANLSH), le ratio entre le glucose entrant et le lactate sortant est de 1. Cependant le relargage du lactate dans les astrocytes PPARP-/- est plus élevé que l'entrée du glucose. L'apport supplémentaire de glucose transformé en lactate pourrait provenir de la dégradation des stocks de glycogène intracellulaire, qui sont partiellement diminués après stimulation dans les cellules PPARP -/-. Un métabolisme plus faible du glucose corrèle avec une réduction de l'import du glutamate dans les astrocytes PPARp -/-. Réciproquement, nous observons une augmentation de l'import du glutamate et de la production d'ATP après traitement avec l'agoniste pour PPARp. Bien que l'expression des transporteurs de glutamate ne soit pas affectée, nous ne pouvons pas exclure que leur localisation et leur structure soient altérées du fait du niveau élevé de cholestérol dans les astrocytes PPARp -/-.Le métabolisme, la localisation des transporteurs et le niveau de cholestérol sont tous liés au cytosquelette, à la mobilité, et à la composition des membranes cellulaires. Toutes ces fonctions sont importantes pour les astrocytes pour acquérir leur morphologie in vivo. Les astrocytes PPARP -/- présentent un défaut de stellation, aussi bien en présence de neurones que de stimuli chimiques, ainsi qu'un plus grand nombre de fibres de stress (actine) et de structures d'adhésion cellulaire. Bien que les astrocytes non stellaires soient principalement observés in vitro, le défaut de stellation des astrocytes primaires PPARp -/- indique une incapacité à répondre aux différents stimuli extérieurs. Ces phénotypes morphologiques corrèlent avec une migration plus lente en cas de lésion de la culture.Ce travail de thèse a permis de démontrer l'implication de PPARP dans le métabolisme du glucose des astrocytes corticaux. L'absence de ce récepteur nucléaire amène à l'utilisation du glucose intracellulaire, auquel s'ajoutent les effets sur l'import du glutamate et la migration des astrocytes. PPARp aurait des effets neuroprotecteurs, et de ce fait pourrait être utilisé à des fins thérapeutiques.

Gastric banding induces negative bone remodelling in the absence of secondary hyperparathyroidism: potential role of serum C telopeptides for follow-up.

OBJECTIVE: Data about the consequences of laparoscopic adjustable gastric banding (LAGB) on phospho-calcic and bone metabolism remain scarce. SUBJECTS: We studied a group of 37 obese premenopausal women (age: 24-52 y; mean BMI = 43.7 kg/m2) who underwent LAGB. METHODS: Serum calcium, phosphate, alkaline phosphatase, parathormone (PTH), vitamin D3, serum C-telopeptides, IGFBP-3 and IGF-1 were measured at baseline, 6, 12, 18 and 24 months after surgery. Body composition, bone mineral content (BMC) and density (BMD) were measured using dual-X-ray absorptiometry (DXA) at baseline, 6, 12 and 24 months after surgery. RESULTS: There was no clinically significant decrease of calcemia; PTH remained stable. Serum telopeptides increased by 100% (P < 0.001) and serum IGFBP-3 decreased by 16% (P < 0.001) during the first 6 months, and then stabilized, whereas IGF-1 remained stable over the 2 y. BMC and BMD decreased, especially at the femoral neck; this decrease was significantly correlated with the decrease of waist and hip circumference. CONCLUSIONS: We concluded that there was no evidence of secondary hyperparathyroidism 24 months after LAGB. The observed bone resorption could be linked to the decrease of IGFBP-3, although this decrease could be attributable to other confounding factors. Serum telopeptides seem to be a reliable marker of bone metabolism after gastric banding. DXA must be interpreted cautiously during major weight loss, because of the artefacts caused by the important variation of fat tissue after LAGB.

Recommandations suisses romandes sur la prise en charge de l'asthme de l'adulte [Lake Geneva Region guidelines on management of adult asthma]

Asthma is a major cause of chronic morbidity throughout the world. In Switzerland, 6.9% of the adult population is suffering from asthma. The standards of treatment are unfortunately not met in most western countries, as well as in Switzerland. We put forward a complete guideline on management of adult asthma, inspired from GINA and BTS guidelines, and adapted to the specific needs of general practitioners working in french part of Switzerland. This guideline reflects a consensus between allergy, lung and emergency specialists, working in the 2 university hospitals of the Lake Geneva Region (HUG and CHUV).

Absence of mTOR Inhibitor Effect on Hepatic Cyst Growth: A Case Report of a Kidney Transplant Recipient with Autosomal Dominant Polycystic Kidney Disease.

Some experimental studies have suggested a beneficial effect of the mammalian target of rapamycin (mTOR) inhibitor use on hepatic and renal cyst growth in patients with autosomal dominant polycystic kidney disease (ADPKD). However, the results of clinical studies are conflicting and the role of mTOR inhibitors is still uncertain. We report the case of a patient with ADPKD who underwent deceased kidney transplantation because of an end-stage renal disease. The evolution was uneventful with an excellent graft function under cyclosporine (CsA) monotherapy. Some years later, the patient developed a symptomatic hepatomegaly due to growth of cysts. CsA was replaced by sirolimus, an mTOR inhibitor, in order to reduce or control the increase in the cyst and liver volume. Despite the switch, the hepatic volume increased by 25% in two years. Finally sirolimus was stopped because of the lack of effect on hepatic cyst growth and the presence of sirolimus side effects. The interest of our case resides in the followup by MRI imaging during the mTOR inhibitor treatment and 15 months after the restart of the initial immunosuppressive therapy. This observation indicates that mTOR inhibitors did not have significant effect on cyst-associated hepatic growth in our patient, which is consistent with some results of recent large clinical studies.